|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q1 FY2024
As of Feb 29, 2024
|
Q4 FY2023
As of Nov 30, 2023
|
Q3 FY2023
As of Aug 31, 2023
|
Q2 FY2023
As of May 31, 2023
|
Q1 FY2023
As of Feb 28, 2023
|
Q4 FY2022
As of Nov 30, 2022
|
Q3 FY2022
As of Aug 31, 2022
|
Q2 FY2022
As of May 31, 2022
|
Q1 FY2022
As of Feb 28, 2022
|
Q4 FY2021
As of Nov 30, 2021
|
Q3 FY2021
As of Aug 31, 2021
|
Q2 FY2021
As of May 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Deposits and prepaids | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaids | ||||||||||||||||||||
| Note receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Non-Current Assets: | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Other asset | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accounts payable – related party | ||||||||||||||||||||
| Accrued officer compensation – related party | ||||||||||||||||||||
| Accrued interest – related party | ||||||||||||||||||||
| Note payable | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Notes payable, net of current portion – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes payable, net of current portion – related party | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Deficit: | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Common stock, $0.01 par value, 250,000,000 shares authorized; 52,815,204 and 49,190,204 shares issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost; 39,975 shares of common stock | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
Loading...
